* Compass Pathways PLC CMPS.OQ reported a quarterly
adjusted
loss of 53 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -73 cents. The mean expectation of
seven analysts for the quarter was for a loss of 33 cents per
share. Wall Street expected results to range from -62 cents
to -24 cents per share.
* Reported revenue was zero; analysts expected zero.
* Compass Pathways PLC's reported EPS for the quarter was a
loss
of 53 cents.
* The company reported a quarterly loss of $32.53 million.
* Compass Pathways PLC shares had risen by 41.4% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Compass Pathways
PLC is $33.00
This summary was machine generated from LSEG data February 29 at
02:33 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.33 -0.53 Missed
Sep. 30 2023 -0.43 -0.67 Missed
Jun. 30 2023 -0.69 -0.62 Beat
Mar. 31 2023 -0.68 -0.57 Beat